Peripheral blood gene expression signatures which reflect smoking and aspirin exposure are associated with cardiovascular events

Abstract Background Cardiovascular disease and its sequelae are major causes of global mortality, and better methods are needed to identify patients at risk for future cardiovascular events. Gene expression analysis can inform on the molecular underpinnings of risk factors for cardiovascular events....

Full description

Saved in:
Bibliographic Details
Main Authors: James A. Wingrove (Author), Karen Fitch (Author), Brian Rhees (Author), Steven Rosenberg (Author), Deepak Voora (Author)
Format: Book
Published: BMC, 2018-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_8ed7b9da99984b25bfecccee2d3ec84b
042 |a dc 
100 1 0 |a James A. Wingrove  |e author 
700 1 0 |a Karen Fitch  |e author 
700 1 0 |a Brian Rhees  |e author 
700 1 0 |a Steven Rosenberg  |e author 
700 1 0 |a Deepak Voora  |e author 
245 0 0 |a Peripheral blood gene expression signatures which reflect smoking and aspirin exposure are associated with cardiovascular events 
260 |b BMC,   |c 2018-01-01T00:00:00Z. 
500 |a 10.1186/s12920-017-0318-6 
500 |a 1755-8794 
520 |a Abstract Background Cardiovascular disease and its sequelae are major causes of global mortality, and better methods are needed to identify patients at risk for future cardiovascular events. Gene expression analysis can inform on the molecular underpinnings of risk factors for cardiovascular events. Smoking and aspirin have known opposing effects on platelet reactivity and MACE, however their effects on each other and on MACE are not well described. Methods We measured peripheral blood gene expression levels of ITGA2B, which is upregulated by aspirin and correlates with platelet reactivity on aspirin, and a 5 gene validated smoking gene expression score (sGES) where higher expression correlates with smoking status, in participants from the previously reported PREDICT trial (NCT 00500617). The primary outcome was a composite of death, myocardial infarction, and stroke/TIA (MACE). We tested whether selected genes were associated with MACE risk using logistic regression. Results Gene expression levels were determined in 1581 subjects (50.5% female, mean age 60.66 +/−11.46, 18% self-reported smokers); 3.5% of subjects experienced MACE over 12 months follow-up. Elevated sGES and ITGA2B expression were each associated with MACE (odds ratios [OR] =1.16 [95% CI 1.10-1.31] and 1.42 [95% CI 1.00-1.97], respectively; p < 0.05). ITGA2B expression was inversely associated with self-reported smoking status and the sGES (p < 0.001). A logistic regression model combining sGES and ITGA2B showed better performance (AIC = 474.9) in classifying MACE subjects than either alone (AIC = 479.1, 478.2 respectively). Conclusion Gene expression levels associated with smoking and aspirin are independently predictive of an increased risk of cardiovascular events. 
546 |a EN 
690 |a Gene expression 
690 |a Smoking 
690 |a Aspirin exposure 
690 |a Cardiovascular events 
690 |a Internal medicine 
690 |a RC31-1245 
690 |a Genetics 
690 |a QH426-470 
655 7 |a article  |2 local 
786 0 |n BMC Medical Genomics, Vol 11, Iss 1, Pp 1-9 (2018) 
787 0 |n http://link.springer.com/article/10.1186/s12920-017-0318-6 
787 0 |n https://doaj.org/toc/1755-8794 
856 4 1 |u https://doaj.org/article/8ed7b9da99984b25bfecccee2d3ec84b  |z Connect to this object online.